Comparison of levobupivacaine with ropivacaine for painless labour
Phase 3
- Conditions
- Health Condition 1: null- Term Pregnant Female Parturients
- Registration Number
- CTRI/2013/09/004007
- Lead Sponsor
- Dr T S Punia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
Singleton Healthy Full Term Pregnancy
ASA physical status I or II
Exclusion Criteria
Breech presentation
Antepartum haemorrhage
Severe pre-eclampsia
Aortic stenosis
Cephalopelvic disproportions
Coagulation defects or anticoagulant therapy
Vertebral deformity
Sensitivity of the drug to be administered
Fetal distress
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Onset of analgesia <br/ ><br>Duration of analgesia <br/ ><br> <br/ ><br>Duration of first stage <br/ ><br>Duration of second stage <br/ ><br>Dose given in each top-up <br/ ><br>Total top-upsTimepoint: Outcome to be studied during and immediately after completion of study <br/ ><br> <br/ ><br>Time taken in hours
- Secondary Outcome Measures
Name Time Method Type of Delivery <br/ ><br>Normal Delivery <br/ ><br>Caesarian section <br/ ><br>Instrumental Delivery <br/ ><br>Complications during analgesia in labour <br/ ><br>Nausea Vomiting <br/ ><br>Pruritis Urinary retention <br/ ><br>Apgar score of neonate <br/ ><br>-1 min <br/ ><br>-5 min <br/ ><br>Any Fetal distressTimepoint: Outcome to be studied during and immediately after completion of study <br/ ><br> <br/ ><br>Time taken in hours